| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | $0 | $5.19 | 12 Feb 2024 | Direct |
| MONRO, INC. | Director | Restricted Stock Award | 31,928 | 12 Aug 2025 | Direct | ||
| ImmunoGen, Inc. | Director | Common Stock | 0 | $29.64 | 13 Sep 2023 | Direct |